RadNet, Inc. (NASDAQ:RDNT) Shares Purchased by Natixis Advisors LLC

Natixis Advisors LLC boosted its position in shares of RadNet, Inc. (NASDAQ:RDNT) by 11.4% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 22,530 shares of the medical research company’s stock after buying an additional 2,305 shares during the period. Natixis Advisors LLC’s holdings in RadNet were worth $1,563,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Janus Henderson Group PLC increased its holdings in shares of RadNet by 108.6% in the 1st quarter. Janus Henderson Group PLC now owns 64,029 shares of the medical research company’s stock valued at $3,112,000 after acquiring an additional 33,335 shares during the period. Lisanti Capital Growth LLC purchased a new position in RadNet during the 3rd quarter worth $2,922,000. Intech Investment Management LLC acquired a new position in RadNet in the second quarter valued at $446,000. Steigerwald Gordon & Koch Inc. raised its holdings in shares of RadNet by 153.9% in the second quarter. Steigerwald Gordon & Koch Inc. now owns 15,470 shares of the medical research company’s stock valued at $911,000 after buying an additional 9,376 shares during the last quarter. Finally, Bleakley Financial Group LLC acquired a new stake in shares of RadNet during the third quarter worth about $750,000. Hedge funds and other institutional investors own 77.90% of the company’s stock.

RadNet Stock Performance

Shares of RDNT stock opened at $81.47 on Tuesday. The company has a current ratio of 2.16, a quick ratio of 2.16 and a debt-to-equity ratio of 0.89. The stock has a 50 day simple moving average of $71.01 and a 200-day simple moving average of $64.21. The company has a market cap of $6.03 billion, a price-to-earnings ratio of -1,192.86 and a beta of 1.75. RadNet, Inc. has a 12-month low of $32.01 and a 12-month high of $93.65.

Insider Buying and Selling

In other RadNet news, insider Ranjan Jayanathan sold 38,557 shares of the business’s stock in a transaction on Tuesday, November 19th. The shares were sold at an average price of $80.00, for a total transaction of $3,084,560.00. Following the sale, the insider now directly owns 192,724 shares in the company, valued at approximately $15,417,920. The trade was a 16.67 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 5.12% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on RDNT shares. Jefferies Financial Group boosted their price target on RadNet from $75.00 to $80.00 and gave the company a “buy” rating in a research report on Thursday, September 19th. Barclays upgraded RadNet from an “equal weight” rating to an “overweight” rating and upped their price target for the stock from $57.00 to $79.00 in a research note on Friday, September 6th. Sidoti raised RadNet to a “strong-buy” rating in a report on Friday, October 4th. Finally, Truist Financial boosted their price objective on shares of RadNet from $70.00 to $80.00 and gave the company a “buy” rating in a research note on Monday, September 23rd. One equities research analyst has rated the stock with a sell rating, four have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $74.75.

About RadNet

RadNet, Inc, together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services.